Cargando…

Defective Protein Catabolism in Atherosclerotic Vascular Inflammation

Vascular inflammation in atheroprone vessels propagates throughout the arterial tree in dyslipidemic patients, thereby accelerating atherosclerotic progression. To elucidate the mechanism of vascular inflammation, most previous studies have focused on inflammation-related signals that are sent in re...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyazaki, Takuro, Miyazaki, Akira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725411/
https://www.ncbi.nlm.nih.gov/pubmed/29270409
http://dx.doi.org/10.3389/fcvm.2017.00079
_version_ 1783285516099125248
author Miyazaki, Takuro
Miyazaki, Akira
author_facet Miyazaki, Takuro
Miyazaki, Akira
author_sort Miyazaki, Takuro
collection PubMed
description Vascular inflammation in atheroprone vessels propagates throughout the arterial tree in dyslipidemic patients, thereby accelerating atherosclerotic progression. To elucidate the mechanism of vascular inflammation, most previous studies have focused on inflammation-related signals that are sent in response to vasoactive stimuli. However, it is also important to understand how normal blood vessels become defective and start degenerating. Growing evidence suggests that major protein catabolism pathways, including the ubiquitin-proteasome, autophagy, and calpain systems, are disturbed in atheroprone vessels and contribute to the pathogenesis of atherosclerosis. Indeed, dysregulation of ubiquitin–proteasome pathways results in the accumulation of defective proteins in blood vessels, leading to vascular endothelial dysfunction and apoptosis in affected cells. Impaired autophagy-lysosomal degradation affects smooth muscle cell transformation and proliferation, as well as endothelial integrity and phagocytic clearance of cellular corpses. Dysregulation of the calpain system confers proatherogenic properties to endothelial cells, smooth muscle cells, and macrophages. In this review article, we will discuss the current information available on defective protein catabolism in atheroprone vessels and its potential interrelation with inflammation-related signals.
format Online
Article
Text
id pubmed-5725411
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-57254112017-12-21 Defective Protein Catabolism in Atherosclerotic Vascular Inflammation Miyazaki, Takuro Miyazaki, Akira Front Cardiovasc Med Cardiovascular Medicine Vascular inflammation in atheroprone vessels propagates throughout the arterial tree in dyslipidemic patients, thereby accelerating atherosclerotic progression. To elucidate the mechanism of vascular inflammation, most previous studies have focused on inflammation-related signals that are sent in response to vasoactive stimuli. However, it is also important to understand how normal blood vessels become defective and start degenerating. Growing evidence suggests that major protein catabolism pathways, including the ubiquitin-proteasome, autophagy, and calpain systems, are disturbed in atheroprone vessels and contribute to the pathogenesis of atherosclerosis. Indeed, dysregulation of ubiquitin–proteasome pathways results in the accumulation of defective proteins in blood vessels, leading to vascular endothelial dysfunction and apoptosis in affected cells. Impaired autophagy-lysosomal degradation affects smooth muscle cell transformation and proliferation, as well as endothelial integrity and phagocytic clearance of cellular corpses. Dysregulation of the calpain system confers proatherogenic properties to endothelial cells, smooth muscle cells, and macrophages. In this review article, we will discuss the current information available on defective protein catabolism in atheroprone vessels and its potential interrelation with inflammation-related signals. Frontiers Media S.A. 2017-12-07 /pmc/articles/PMC5725411/ /pubmed/29270409 http://dx.doi.org/10.3389/fcvm.2017.00079 Text en Copyright © 2017 Miyazaki and Miyazaki. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Miyazaki, Takuro
Miyazaki, Akira
Defective Protein Catabolism in Atherosclerotic Vascular Inflammation
title Defective Protein Catabolism in Atherosclerotic Vascular Inflammation
title_full Defective Protein Catabolism in Atherosclerotic Vascular Inflammation
title_fullStr Defective Protein Catabolism in Atherosclerotic Vascular Inflammation
title_full_unstemmed Defective Protein Catabolism in Atherosclerotic Vascular Inflammation
title_short Defective Protein Catabolism in Atherosclerotic Vascular Inflammation
title_sort defective protein catabolism in atherosclerotic vascular inflammation
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725411/
https://www.ncbi.nlm.nih.gov/pubmed/29270409
http://dx.doi.org/10.3389/fcvm.2017.00079
work_keys_str_mv AT miyazakitakuro defectiveproteincatabolisminatheroscleroticvascularinflammation
AT miyazakiakira defectiveproteincatabolisminatheroscleroticvascularinflammation